217 related articles for article (PubMed ID: 17468771)
1. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma.
Sung KW; Lee SH; Yoo KH; Jung HL; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
Bone Marrow Transplant; 2007 Jul; 40(1):37-45. PubMed ID: 17468771
[TBL] [Abstract][Full Text] [Related]
2. High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center.
Suh JM; Yoo KH; Sung KW; Kim JY; Cho EJ; Koo HH; Lee SK; Kim J; Lim DH; Suh YL; Kim DW
J Korean Med Sci; 2009 Aug; 24(4):660-7. PubMed ID: 19654949
[TBL] [Abstract][Full Text] [Related]
3. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
[TBL] [Abstract][Full Text] [Related]
4. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma: the Korean Society of Pediatric Hematology-Oncology experience over 6 years (2000-2005).
Sung KW; Ahn HS; Cho B; Choi YM; Chung NG; Hwang TJ; Im HJ; Jeong DC; Kang HJ; Koo HH; Kook H; Kim HK; Lyu CJ; Seo JJ; Shin HY; Yoo KH; Won SC; Lee KS
J Korean Med Sci; 2010 May; 25(5):691-7. PubMed ID: 20436703
[TBL] [Abstract][Full Text] [Related]
6. Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.
Modak S; Gardner S; Dunkel IJ; Balmaceda C; Rosenblum MK; Miller DC; Halpern S; Finlay JL
J Clin Oncol; 2004 May; 22(10):1934-43. PubMed ID: 15143087
[TBL] [Abstract][Full Text] [Related]
7. Successive double high-dose chemotherapy with peripheral blood stem cell rescue collected during a single leukapheresis round in patients with high-risk pediatric solid tumors: a pilot study in a single center.
Sung KW; Yoo KH; Chung EH; Jung HL; Koo HH; Shin HJ; Lee SK; Lim DH; Kim DW; Park HK; Cho EJ; Kim SW
Bone Marrow Transplant; 2003 Mar; 31(6):447-52. PubMed ID: 12665839
[TBL] [Abstract][Full Text] [Related]
8. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
[TBL] [Abstract][Full Text] [Related]
9. Tandem high-dose chemotherapy and autologous stem cell rescue in children with bilateral advanced retinoblastoma.
Lee SH; Yoo KH; Sung KW; Kim JY; Cho EJ; Koo HH; Chung SE; Kang SW; Oh SY; Ham DI; Kim YD
Bone Marrow Transplant; 2008 Sep; 42(6):385-91. PubMed ID: 18574441
[TBL] [Abstract][Full Text] [Related]
10. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.
Gururangan S; McLaughlin C; Quinn J; Rich J; Reardon D; Halperin EC; Herndon J; Fuchs H; George T; Provenzale J; Watral M; McLendon RE; Friedman A; Friedman HS; Kurtzberg J; Vredenbergh J; Martin PL
J Clin Oncol; 2003 Jun; 21(11):2187-91. PubMed ID: 12775745
[TBL] [Abstract][Full Text] [Related]
12. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of high-dose
Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
[TBL] [Abstract][Full Text] [Related]
14. High dose chemotherapy and autologous stem cell transplantation in patients with multiple myeloma: the experience of a single haematological unit.
Papanikolaou X; Maltezas D; Repousis P; Athanassopoulos A; Alexia S; Megalakaki K; Kotsopoulou M; Mitsouli-Mentzikof C
J BUON; 2008; 13(2):193-7. PubMed ID: 18555464
[TBL] [Abstract][Full Text] [Related]
15. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Bradfield SM; Douglas JG; Hawkins DS; Sanders JE; Park JR
Cancer; 2004 Mar; 100(6):1268-75. PubMed ID: 15022296
[TBL] [Abstract][Full Text] [Related]
16. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
17. Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma.
Valteau-Couanet D; Benhamou E; Vassal G; Stambouli F; Lapierre V; Couanet D; Lumbroso J; Hartmann O
Bone Marrow Transplant; 2000 May; 25(9):937-42. PubMed ID: 10800060
[TBL] [Abstract][Full Text] [Related]
18. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant.
von Allmen D; Grupp S; Diller L; Marcus K; Ecklund K; Meyer J; Shamberger RC
J Pediatr Surg; 2005 Jun; 40(6):936-41; discussion 941. PubMed ID: 15991174
[TBL] [Abstract][Full Text] [Related]
19. Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation.
Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Wolf J; Nyström M; Hovi L
Bone Marrow Transplant; 2002 Jan; 29(2):121-7. PubMed ID: 11850706
[TBL] [Abstract][Full Text] [Related]
20. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
